Department of Nursing, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Front Public Health. 2023 Feb 16;11:1112383. doi: 10.3389/fpubh.2023.1112383. eCollection 2023.
Post-acute coronavirus disease 2019 (COVID-19) symptoms occurred in most of the COVID-19 survivors. However, few studies have examined the issue of whether hospitalization results in different post-acute COVID-19 symptom risks. This study aimed to compare potential COVID-19 long-term effects in hospitalized and non-hospitalized COVID-19 survivors.
This study is designed as a systematic review and meta-analysis of observational studies. A systematic search of six databases was performed for identifying articles published from inception until April 20th, 2022, which compared post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors using a predesigned search strategy included terms for SARS-CoV-2 (eg, , and ), post-acute COVID-19 Syndrome (eg, , and ), and hospitalization (, and ). The present meta-analysis was conducted according to The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement using R software 4.1.3 to create forest plots. Q statistics and the index were used to evaluate heterogeneity in this meta-analysis.
Six observational studies conducted in Spain, Austria, Switzerland, Canada, and the USA involving 419 hospitalized and 742 non-hospitalized COVID-19 survivors were included. The number of COVID-19 survivors in included studies ranged from 63 to 431, and follow-up data were collected through visits in four studies and another two used an electronic questionnaire, visit and telephone, respectively. Significant increase in the risks of long dyspnea (OR = 3.18, 95% CI = 1.90-5.32), anxiety (OR = 3.09, 95% CI = 1.47-6.47), myalgia (OR = 2.33, 95% CI = 1.02-5.33), and hair loss (OR = 2.76, 95% CI = 1.07-7.12) risk were found in hospitalized COVID-19 survivors compared with outpatients. Conversely, persisting ageusia risk was significantly reduced in hospitalized COVID-19 survivors than in non-hospitalized patients.
The findings suggested that special attention and patient-centered rehabilitation service based on a needs survey should be provided for hospitalized COVID-19 survivors who experienced high post-acute COVID-19 symptoms risk.
大多数 COVID-19 幸存者都出现了急性新冠病毒病 2019 (COVID-19)后症状。然而,很少有研究探讨住院是否会导致不同的急性 COVID-19 后症状风险。本研究旨在比较住院和非住院 COVID-19 幸存者的潜在 COVID-19 长期影响。
本研究设计为系统综述和观察性研究的荟萃分析。使用预设的搜索策略对六个数据库进行了系统搜索,该策略包括 SARS-CoV-2(例如, , 和 )、急性新冠病毒病 2019 后综合征(例如, , 和 )和住院( , 和 )等术语,以比较住院和非住院 COVID-19 幸存者的急性 COVID-19 后症状风险。本荟萃分析根据 2020 年系统评价和荟萃分析首选报告项目(PRISMA)声明使用 R 软件 4.1.3 进行,以创建森林图。Q 统计量和 I 2 指数用于评估本荟萃分析中的异质性。
纳入了西班牙、奥地利、瑞士、加拿大和美国进行的六项观察性研究,涉及 419 名住院和 742 名非住院 COVID-19 幸存者。纳入研究的 COVID-19 幸存者人数从 63 人到 431 人不等,通过四项研究中的随访访问收集数据,另外两项研究分别使用电子问卷、访问和电话收集数据。与门诊患者相比,住院 COVID-19 幸存者出现长期呼吸困难(OR = 3.18,95%CI = 1.90-5.32)、焦虑(OR = 3.09,95%CI = 1.47-6.47)、肌痛(OR = 2.33,95%CI = 1.02-5.33)和脱发(OR = 2.76,95%CI = 1.07-7.12)风险显著增加。相反,与非住院患者相比,住院 COVID-19 幸存者持续性味觉丧失的风险显著降低。
研究结果表明,对于经历急性 COVID-19 后症状风险较高的住院 COVID-19 幸存者,应提供特殊关注和基于需求调查的以患者为中心的康复服务。